Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
New Medicine Partners (NMP) is a London-based consulting firm focused on healthy longevity and precision preventive medicine. It is not a typical SaaS or enterprise software platform. Its work centers on AI-enabled precision medicine, healthspan extension, preventive healthcare technology translation, and health system optimization, serving government agencies, investors, healthcare providers, SMEs, startups, and research institutions.
NMP’s services are organized around three main areas. First, longevity technology translation and commercialization, including technology assessment, market positioning, business planning, strategic partnerships, IP valuation, and fundraising strategy. Second, health system optimization, helping countries, providers, and payers develop healthy longevity strategies, while supporting the use of AI in population analysis, early intervention, and personalized clinical decision-making. Third, healthy longevity clinic consulting, covering product-line strategy, regulatory requirements, equipment and capacity planning, marketing and customer acquisition, operational workflows, and financing/business plans.
The website does not disclose specific pricing, packages, or subscription models. In the clinic consulting section, it only states that services are modular and can be priced and delivered separately by module, with some modules dependent on others. Before procurement, buyers should therefore request a quote by email and clearly define the project scope, deliverables, timeline, and division of responsibilities.
Its strengths lie in its deep vertical focus, covering key steps from early-stage technology, market access, and commercialization to clinical application. The site also discloses project or client examples including Royal Society of Medicine, Kemijski Institut, KSS AHSN, and Veratrak. NMP emphasizes that it does not outsource work or use junior analysts, making it suitable for projects that require high-level expert judgment. The downside is that the website provides no information about a software platform, APIs, integrations, permission management, deployment options, or security certifications, so it is not well suited to evaluation as a standard enterprise software purchase.
NMP is better suited to founders of longevity clinics, medical technology startups, technology transfer teams at research institutions, investors, and health system decision-makers. Chinese organizations considering collaboration should verify cross-border consulting delivery, English-language communication, payment methods, differences in medical regulation, and data compliance requirements. There is no reliable information on the website’s accessibility from China. Alternatives could include local healthcare strategy consultancies, market access advisors, CRO/translational medicine service providers, or digital health solution companies.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on newmedicine.io official site.
newmedicine.io is an Unknown SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach newmedicine.io directly.